These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1790279)

  • 1. [Infectivity by HIV of different blood products used in Aragon].
    Lucia Cuesta JF; García Aranda A
    An Med Interna; 1991 Nov; 8(11):548-50. PubMed ID: 1790279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
    Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
    Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to acellular blood products and risk of HIV infection in hemophiliacs from Belo Horizonte, Brazil.
    Proietti FA; Proietti AB; Costa MF; Antunes CM; Guimarães MD; Paulino UH; Souza CJ; Melo L; Muñoz A
    Rev Inst Med Trop Sao Paulo; 1992; 34(3):227-32. PubMed ID: 1342075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of replacement therapy on the evolution of HIV infection in hemophiliacs.
    Berntorp E
    Thromb Haemost; 1994 Jun; 71(6):678-83. PubMed ID: 7974331
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV-antibody seroconversions in Dutch haemophiliacs using heat-treated and non heat-treated coagulation factor concentrates.
    Wolfs TF; Breederveld C; Krone WJ; vd Hoek L; Bakker M; Smit L; Goudsmit J
    Thromb Haemost; 1988 Jun; 59(3):396-9. PubMed ID: 3142077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV seroconversion in Thai hemophiliacs up to 1991.
    Isarangkura P; Chuansumrit A; Hathirat P; Panthangkura W; Mahaphan W; Limsuwan A; Chiewsilp P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():191-4. PubMed ID: 7886571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States?
    Mosley JW
    Vox Sang; 1994; 67 Suppl 4():12-5; discussion 24-6. PubMed ID: 7831863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
    Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
    AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A in French hemophiliacs.
    Goudemand J; Parquet A; d'Oiron R; Stieltjes N; Guérois C; Fonlupt J; Alcalay M; Négrier C; Cazenave JP; Briquel ME
    Vox Sang; 1994; 67 Suppl 1():9-12; discussion 13. PubMed ID: 8091745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
    Abe T
    AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan.
    Ikegami N
    AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV seroprevalence in hematologic patients other than hemophiliacs at Ramathibodi Hospital.
    Mahaphan W; Hathirat P; Isarangkura P; Chuansumrit A; Atnaseo P; Panthangkura W; Chiewsilp P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():187-90. PubMed ID: 7886570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of HTLV-III/LAV seroconversion and non-A, non-B hepatitis in recipients of plasma products.
    Piszkiewicz D; Kingdon H; Lee ML; Hooper J
    Dev Biol Stand; 1987; 67():327-31. PubMed ID: 2440745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO
    Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human immunodeficiency virus infection in hemophiliacs: prevalence and current clinical situation].
    Lorenzo JI; Molina R; Arilla MJ; Dasí MA; Monteagudo E; Aznar JA
    Sangre (Barc); 1991 Dec; 36(6):451-5. PubMed ID: 1812578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment of patients with inhibitors to factor VIII.
    Hilgartner MW
    Haematologia (Budap); 1986; 19(1):21-32. PubMed ID: 3087840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV and Canada's hemophiliacs: looking back at a tragedy.
    Dunn K
    CMAJ; 1993 Feb; 148(4):609-12. PubMed ID: 8431823
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody to hepatitis C virus after a vapour-heated factor VIII concentrate. The Study Group of the Fondazione dell'Emofilia.
    Mannucci PM; Zanetti AR; Colombo M; Chistolini A; De Biasi R; Musso R; Tamponi G
    Thromb Haemost; 1990 Oct; 64(2):232-4. PubMed ID: 2176748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the hepatitis A epidemics in hemophiliacs in Europe.
    Vermylen J; Peerlinck K
    Vox Sang; 1994; 67 Suppl 4():8-11; discussion 24-6. PubMed ID: 7831867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Suppression of factor VIII inhibitor in children with hemophilia A].
    Zenz W; Muntean W
    Padiatr Padol; 1987; 22(4):345-52. PubMed ID: 3125510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.